United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 24.75 kg in 25 kg

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 12375 g in 12500 g

United States - English - NLM (National Library of Medicine)

elanco us inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn), silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - baytril otic is indicated as a treatment for canine otitis externa complicated by bacterial and fungal organisms susceptible to enrofloxacin and/or silver sulfadiazine (see microbiology section). baytril otic is contraindicated in dogs with suspected or known hypersensitivity to quinolones and/or sulfonamides.

Spain - English - HMA (Heads of Medicines Agencies)

universal farma s.l. - enrofloxacin 100 mg/ml - oral solution - chicken food, rabbit food - enrofloxacin

Italy - English - HMA (Heads of Medicines Agencies)

universal farma s.l. - enrofloxacin 100 mg/ml - oral solution - chicken food, rabbit food - enrofloxacin

Portugal - English - HMA (Heads of Medicines Agencies)

universal farma s.l. - enrofloxacin 100 mg/ml - oral solution - chicken food, rabbit food - enrofloxacin

United States - English - NLM (National Library of Medicine)

professional group of pharmacists new york llc - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) -

United States - English - NLM (National Library of Medicine)

sparhawk laboratories, inc - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - cattle-single-dose therapy:  enrofloxacin 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis . cattle-multiple-day therapy:  enrofloxacin 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni in beef and non-lactating dairy cattle. swine:  enrofloxacin 100 is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis, bordetella bronchiseptica and mycoplasma hyopneumoniae.  enrofloxacin 100 is indicated for the control of colibacillosis in groups or pens of weaned pigs where colibacillosis associated with escherichia coli has been diagnosed.

United States - English - NLM (National Library of Medicine)

novartis animal health us, inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg

United States - English - NLM (National Library of Medicine)

darmerica, llc - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) -